ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Genfit

Genfit (XUP)

3.645
0.00
( 0.00% )
Updated: 10:26:10
Realtime Data

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
3.645
Bid
3.53
Ask
3.56
Volume
0.00
0.00 Day's Range 0.00
3.06 52 Week Range 5.77
Previous Close
3.645
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
1,022
Financial Volume
-
VWAP
-

XUP Latest News

GENFIT Announces Corporate Updates and Upcoming Participation at The Liver Meeting® 2024

GENFIT Announces Corporate Updates and Upcoming Participation at The Liver Meeting® 2024 PBC program (licensed to Ipsen): Ipsen to present new data on elafibranor at The Liver Meeting® 2024Launch...

GENFIT fait un point d’actualité sur ses activités à l’occasion de sa participation prochaine à l’AASLD Liver Meeting® 2024

GENFIT fait un point d’actualité sur ses activités à l’occasion de sa participation prochaine à l’AASLD Liver Meeting® 2024 Programme PBC (sous licence Ipsen) : Ipsen présentera de nouvelles...

GENFIT Reports Third Quarter 2024 Financial Information

GENFIT Reports Third Quarter 2024 Financial Information Cash and cash equivalents totaled €96.0 million as of September 30, 2024€59.7 million in revenues for the nine months ended September 30...

GENFIT : Information financière du troisième trimestre 2024

GENFIT : Information financière du troisième trimestre 2024 Trésorerie et équivalents de trésorerie s’élevant à 96,0 millions d’euros au 30 septembre 202459,7 millions d’euros de revenus des neuf...

GENFIT: Ipsen’s Iqirvo® (Elafibranor) Receives EU Approval as a First-in-Class Treatment for Primary Biliary Cholangitis following U.S. FDA Accelerated Approval

GENFIT: Ipsen’s Iqirvo® (Elafibranor) Receives EU Approval as a First-in-Class Treatment for Primary Biliary Cholangitis following U.S. FDA Accelerated Approval Lille (France), Cambridge...

GENFIT : Iqirvo® d’Ipsen (elafibranor) reçoit l’approbation UE en tant que traitement first-in-class de la Cholangite Biliaire Primitive consécutivement à l’approbation accélérée de la FDA américaine

GENFIT : Iqirvo® d’Ipsen (elafibranor) reçoit l’approbation UE en tant que traitement first-in-class de la Cholangite Biliaire Primitive consécutivement à l’approbation accélérée de la FDA...

GENFIT Reports First Half-Year 2024 Financial Results and Provides Corporate Update

GENFIT Reports First Half-Year 2024 Financial Results and Provides Corporate Update Cash and cash equivalents totaled €61.6 million as of June 30, 2024, excluding the €48.7 million milestone...

GENFIT : Résultats financiers du premier semestre 2024 et point sur les activités de la Société

GENFIT : Résultats financiers du premier semestre 2024 et point sur les activités de la Société Trésorerie et équivalents de trésorerie s’élevant à 61,6 millions d’euros au 30 juin 2024 n’incluant...

GENFIT: Positive Opinion from EMA Committee for Ipsen’s Iqirvo® (elafibranor) in Primary Biliary Cholangitis

GENFIT: Positive Opinion from EMA Committee for Ipsen’s Iqirvo® (elafibranor) in Primary Biliary Cholangitis Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), July...

GENFIT : Avis positif du Comité des médicaments à usage humain (CHMP) pour l’Iqirvo® (élafibranor) d’Ipsen dans la Cholangite Biliaire Primitive

GENFIT : Avis positif du Comité des médicaments à usage humain (CHMP) pour l’Iqirvo® (élafibranor) d’Ipsen dans la Cholangite Biliaire Primitive Lille (France), Cambridge (Massachusetts...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.071.958041958043.5753.623.57515643.5796914DE
4-0.085-2.278820375343.733.733.4158743.53671704DE
12-1.835-33.48540145995.485.773.41510224.42660451DE
26-0.22-5.692108667533.8655.773.41512344.42548717DE
520.113.11173974543.5355.773.0614304.25897962DE
1560.143.994293865913.5055.772.85514124.02470939DE
2600.143.994293865913.5055.772.85514124.02470939DE

XUP - Frequently Asked Questions (FAQ)

What is the current Genfit share price?
The current share price of Genfit is 3.645 €
What is the 1 year trading range for Genfit share price?
Genfit has traded in the range of 3.06 € to 5.77 € during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
3SXOKEA AS
9.6754 €
(419.07%)
4.5k
7KOCullinan Metals Corp
0.0216 €
(80.00%)
1.5k
A8DAb Science
2.225 €
(73.56%)
67.14k
E3O1Nexoptic Technology Corp
0.0265 €
(70.97%)
19.61k
H1NMetasphere Labs Inc
0.1285 €
(64.74%)
673.17k
L7C2Windfall Geotek Inc
0.003 €
(-64.71%)
1.32k
LL3PanGenomic Health Inc
0.0766 €
(-39.40%)
400
0PV2Moovly Media Inc
0.003 €
(-33.33%)
140.76k
55UAdtiger Corporations Limited
0.009 €
(-30.77%)
7.13k
POTAPortofino Resources Inc
0.006 €
(-30.23%)
10.08k
Y31Infinitii Ai Inc
0.0645 €
(41.76%)
11.49M
PF8European Lithium Limited
0.0284 €
(5.97%)
4.94M
76M0Realbotix Corp
0.332 €
(-13.54%)
4.08M
D7GNel ASA
0.2651 €
(-1.41%)
4.07M
3CPXiaomi Corporation
4.2575 €
(-5.53%)
3.63M

Discussion

View Full Feed
bigbux1 bigbux1 3 minutes ago
Almost chewed through the whole 260 mill OS!
CERO
Gizzer211 Gizzer211 3 minutes ago
Lots of .01s going off, need OTCN off ask 
UMAV
fricassee fricassee 3 minutes ago
Movano
4 - Statements of Changes in Beneficial Ownership
https://ir.movano.com/websites/movano/English/2000/reports-_-filings-_-financials.html#secfiling
LQMT
lakers17 lakers17 3 minutes ago
My posts very greatly but my overall opinion will not change and will be stated until BCDS proves otherwise. Just like you were dead wrong on NSA*. I see the same thing going on here. No OTC whales here and 53 followers of the BCDS thread? Laughable. So far almost no one is buying this story.
BCDS
shurtha2000 shurtha2000 3 minutes ago
Nothing surprises me on how far they are willing to go
NYD NYD 3 minutes ago
Morg, any update from Orie? Thanks!
vlispxpert vlispxpert 3 minutes ago
INO meep meep ;)
INO
pennyonfire pennyonfire 3 minutes ago
.0006s getting loaded today.
GRLT
DawgTrading DawgTrading 3 minutes ago
Good volume... lets see if she breaks higher.
UMAV
mzasif mzasif 4 minutes ago
$CERO .077 up 82% volume 333m+ >> May see 200%-300% Run here!
CERO
noradio noradio 4 minutes ago
Right here... halts for public interest concerns or news pending. As we know news pending was given as the reason for the trading halt by CIRO.

https://www.finra.org/rules-guidance/notices/13-13#:~:text=%2C%20which%20provides%20authority%20for%20FINRA%20to%20initiate,regulatory%20hal
TWOH
XMaster2023 XMaster2023 4 minutes ago
Yes, the platform makes sense for Merck, AstraZenica, Oncovir, and who else?
NWBO
Lakota-45 Lakota-45 4 minutes ago
Yes - and his " 3 " post's have had more substance, than many here
. . . have had in the last years !!! - IMO

~ Lol

~ $WDLF / Decentral Life ~
WDLF
Starlost Starlost 4 minutes ago
STOP THE DILUTION!!! GEEZ!!!!

Let it breathe for once.
TKMO
koolmc koolmc 4 minutes ago
not much volume here so far, understandable since this is the lesser known one to go from em to pink.
EATR
ddls ddls 4 minutes ago
Even the pumpers rhetoric is drying up.😎

A good indication they have run out of any hope this is going to become a winner pink stock.🤠
BIEL
Sonic Boom Sonic Boom 5 minutes ago
Looks like your Spidey senses were correct
XRPUSD
JusDePomme JusDePomme 5 minutes ago
I tell myself cool down the worst is over! Good thing wall .0004 get wack actually! Now looking forward buyers attack ask!
AFFU
igotthemojo igotthemojo 5 minutes ago
Buy sell, buy sell, buy sell and I’m done for the day…no sense getting greedy…

EASY money
FCEL
hondaboost hondaboost 5 minutes ago
Wow!!! CERo : 1 for 100 R/S: Therapeutics Holdings, Inc. Announces Reverse Stock Split

2025-01-06 08:00 ET - News Release


SOUTH SAN FRANSCISCO, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (Nasdaq: CERO) (“CERo” or the “Company”) a
CERO
fwb fwb 5 minutes ago
I believe the poster is talking about the PATENTS SOUNDHOUND HAVE

How many patents does SoundHound have?
https://insights.greyb.com/soundhound-patents/
SoundHound has a total of 344 patents globally. These patents belong to 133 unique patent families. Out of 344 patents,
SOUN
glenn1919 glenn1919 5 minutes ago
syra..................................https://stockcharts.com/h-sc/ui?s=syra&p=W&b=5&g=0&id=p86431144783
SYRA
jog49 jog49 5 minutes ago
"Ackmann cannot say it out loud, as he will be called a greedy hedge fund, trying to milk the tax payer and not worried about safety and soundness blah bla blah."

LOL! I see him as a hyena around a fresh kil by the lions, I seriously doubt he cares if you get a piece of the meat or no
FNMA
The_Edge The_Edge 5 minutes ago
#11 on breakout boards , this one under the radar a bit
FDCT
getmoreshares getmoreshares 5 minutes ago
showing 1.5m ask at 4-- likely higher-- there is a broker hiding
KATX

Your Recent History

Delayed Upgrade Clock